A history of success in genomics, technological innovation & business
Founder & former CEO of Celmatix, a leader in genomics and pharma target generation of women’s health. Laura is a graduate of the Weill Cornell Graduate School of Medical Sciences and Memorial Sloan Kettering Cancer Center doctoral program.
Founding partner at venture fund SOSVs life sciences practice, co-founder of Coder Dojo and currently runs RebelBio in Europe. Bill is an entrepreneur, venture investor, diplomat, author, and speaker with a distinguished record in the areas of business, development and community activism.
Head of Corporate Development of ACC Group, focused on the engineering sector across MENA. Sami is an active investor and previously a board member of Synthace Ltd.
Managing director of JLC Precision Health Strategies, LLC., which partners with executives and investors to advise data-driven healthcare and life science companies on their commercial and financing strategy, and on the development of novel products and services. Jennifer was previously the founder and CEO of TrialzOWN, Inc., a healthcare company in stealth that was acquired by Integral Health (now Valo Health). Also previously the founder and president of N-of-One®, Inc. Jennifer led the creation of award-winning solutions that delivered novel treatment strategies to hundreds of thousands of cancer patients globally. She served as acting-CEO from 2008-2012, and chief medical officer from 2012 until its acquisition by Qiagen (Market Cap $8B). Jennifer graduated Phi Beta Kappa, Summa Cum Laude with distinction with a BS in Molecular Biophysics and Biochemistry from Yale University, an MD from Harvard Medical School, an MPH from Harvard School of Public Health, and an MBA from the Sloan School at Massachusetts Institute of Technology.